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The 1.8 Å crystal structure of catechol 1,2-dioxygenase reveals a
novel hydrophobic helical zipper as a subunit linker
Matthew W Vetting and Douglas H Ohlendorf*
Background: Intradiol dioxygenases catalyze the critical ring-cleavage step in
the conversion of catecholate derivatives to citric acid cycle intermediates.
Catechol 1,2-dioxygenases (1,2-CTDs) have a rudimentary design 
structure — a homodimer with one catalytic non-heme ferric ion per monomer,
that is (αFe3+)2. This is in contrast to the archetypical intradiol dioxygenase
protocatechuate 3,4-dioxygenase (3,4-PCD), which forms more diverse
oligomers, such as (αβFe3+)2–12.
Results: The crystal structure of 1,2-CTD from Acinetobacter sp. ADP1
(Ac 1,2-CTD) was solved by single isomorphous replacement and refined to
2.0 Å resolution. The structures of the enzyme complexed with catechol and
4-methylcatechol were also determined at resolutions of 1.9 Å and 1.8 Å,
respectively. While the characteristics of the iron ligands are similar,
Ac 1,2-CTD differs from 3,4-PCDs in that only one subunit is used to fashion
each active-site cavity. In addition, a novel ‘helical zipper’, consisting of five
N-terminal helices from each subunit, forms the molecular dimer axis. Two
phospholipids were unexpectedly found to bind within an 8 × 35 Å hydrophobic
tunnel along this axis. 
Conclusions: The helical zipper domain of Ac 1,2-CTD has no equivalent in
other proteins of known structure. Sequence analysis suggests the domain is a
common motif in all members of the 1,2-CTD family. Complexes with catechol
and 4-methylcatechol are the highest resolution complex structures to date of
an intradiol dioxygenase. Furthermore, they confirm several observations seen in
3,4-PCDs, including ligand displacement upon binding exogenous ligands. The
structures presented here are the first of a new family of intradiol dioxygenases.
Introduction
Dioxygenases play an important role in the aerobic
catabolism of a number of natural and xenobiotic aro-
matic compounds in the environment. In these path-
ways, a large array of aromatic compounds are converted
into relatively few intermediates that contain two adja-
cent hydroxyl groups. These intermediates then
undergo the critical step of ring cleavage, in which both
atoms of molecular oxygen are incorporated concomi-
tantly by dioxygenases. These enzymes are subdivided
into two classes termed intradiol and extradiol dioxyge-
nases, depending on the point of cleavage on the aro-
matic ring. Both classes typically incorporate a non-heme
iron as a cofactor; intradiol enzymes contain a ferric ion
(Fe3+) and extradiol enzymes typically contain a ferr-
ous ion (Fe2+). Catechol 1,2 dioxygenase (1,2-CTD,
catechol:oxygen 1,2-oxidoreductase [decyclizing]; EC
1.13.11.1) catalyzes an intradiol cleavage reaction of cate-
chol to form cis,cis-muconate.
The structures of several extradiol enzymes have been
solved to date: 2,3-dihydroxybiphenyl dioxygenase [1–3],
catechol 2,3-dioxygenase [4] and protocatechuate
4,5-dioxygenase [5]. These enzymes typically have a
ferrous ion ligated by two histidine residues and a car-
boxylate (in what has been termed for a variety of
mononuclear non-heme iron enzymes as a 2-His-1-car-
boxylate facial triad [6].) The iron atom is capable of
binding both substrate and oxygen simultaneously, and in
the process oxygen is activated towards nucleophilic
attack of a carbon in the aromatic ring.
Dioxygenases that cleave catecholates in an intradiol
fashion can be divided into two families—3,4-PCDs and
1,2-CTDs. 3,4-PCDs are specific for hydroxybenzoates as a
substrate and are typically composed of two homologous
but non-identical subunits in large oligomeric complexes
[αβFe3+]2–12. Two X-ray structures of 3,4-PCDs are known
—from Pseudomonas putida (Pp 3,4-PCD) [7,8] and from
Acinetobacter sp. ADP1 (Ac 3,4-PCD; MWV, unpublished
observations) [9,10]. An abundance of biochemical and
spectroscopic data has been collected from several different
sources—P. putida [11–15], Burkholderia cepacia [16,17],
and Brevibacterium fuscum [14,18–20]. The ferric ion is
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ligated by two histidine residues, two tyrosine residues, and
a hydroxyl ion in trigonal-bipyramidal geometry. As the
non-heme iron atom remains as Fe3+ in all stages of the
reaction, intradiol dioxygenases are unable to directly ligate
and activate molecular oxygen. Instead, it is proposed that
dianionic binding and ketonization of the substrate concen-
trates the electron density on an aromatic carbon, leading to
electrophilic attack by oxygen [18,20]. The structure of Pp
3,4-PCD in complex with substrate demonstrates that the
substrate is chelated to the ferric ion, with the concomitant
dissociation of an axial tyrosine [21,22]. 
Catechol intradiol dioxygenases can be divided into
several subcategories depending on their substrate speci-
ficity. Those that are specific for catechol, chlorocatechols
and hydroxyquinols have been purified and biochemically
studied. Members of the 1,2-CTD family have been crys-
tallized from several sources [23–25]. All known members
of this family apart from one exception are homodimers
[αFe3+]2 with monomer molecular weights between 30
and 40 kDa. The exception to this rule is 1,2-CTD from
Pseudomonas arvilla, which has two highly homologous
monomers that can associate to form homodimers or het-
erodimers [26–28]. Despite the difference in oligomeric
structures, there is significant sequence homology
between all intradiol dioxygenases, indicating that
3,4-PCDs and 1,2-CTDs share a common tertiary fold.
Several biochemical and spectroscopic studies demon-
strate that 3,4-PCDs and 1,2-CTDs have similar mecha-
nisms [13,29,30]. In addition to the iron ligands, several
other catalytically important residues are conserved in all
intradiol dioxygenases. 
In this study we present the crystal structure of 1,2-CTD
from Acinetobacter calcoaceticus ADP1 (Ac 1,2-CTD) at
2.0 Å resolution. The structure shows that each monomer
contains a 3,4-PCD-like domain and a unique helical
N-terminal domain. The helices of this domain interdigi-
tate to form the dimer and also create an interesting
hydrophobic tunnel in which two phospholipid molecules
were found to be bound. This is the first structure to show
such a helical-zipper domain and is the first structure of a
member of the 1,2-CTD family of intradiol dioxygenases.
Sequence alignments indicate that this helical domain is
conserved among the other members of the 1,2-CTD
family. The discovery of phospholipid binding to
1,2-CTD suggests that the phospholipid might modulate
the activity of 1,2-CTD, or that 1,2-CTD might partici-
pate in altering the phospholipid bilayer in response to
toxic levels of aromatic hydrocarbons. The structures of
complexes of Ac 1,2-CTD with catechol and 4-methylcat-
echol are also determined. The complexes reinforce the
proposal that exogenous ligand displacement upon
binding substrate is a general mechanism that is used by
all intradiol dioxygenases. In addition, the complexes
provide important information on which particular
residues are important for the different substrate specifici-
ties of enzymes in the 1,2-CTD family. 
Results and discussion
Structure determination
Crystal nucleation of Ac 1,2-CTD was a rare event;
however, reproducible large crystals were obtained
through seeding procedures [31]. The structure was
solved by single isomorphous replacement (SIR) along
with density modification. The statistics for data collec-
tion, phasing and structure refinement are summarized in
Table 1. The 2Fo–Fc density is of good quality throughout
the map. The structure shows that the monomers are
related by a noncrystallographic twofold. In each
monomer, the native and complex structures include
residues 3–311, one Fe3+, and one phospholipid. 
The electron density for the phospholipid did not extend
to the head group, and therefore its identity could not be
determined. In addition, the length of each tail group was
based on the length of the electron density and the stereo-
chemistry of known phospholipids. Using these restric-
tions, a C10/C15 phosphotidylcholine was used as a model
for the electron density. Electrospray mass spectroscopy
indicated that the purified protein had the expected
monomer molecular mass of 34,341. Additional peaks at
451, 563 and 704 Da suggest that several different phos-
pholipids might be binding at the same time. Ac 1,2-CTD
exhibits three bands on native homogenous polyacry-
lamide gels and one band on SDS gels (data not shown).
The three bands invariably have an equal intensity
throughout the purification, and did not change upon
extended dialysis. The three different ‘forms’ of
Ac 1,2-CTD could not be separated by a DEAE ion-
exchange column, but appeared as three peaks on a
phenyl sepharose hydrophobic-exchange column. These
observations suggest that the three forms might be
Ac 1,2-CTD with no phospholipids, one phospholipid and
two phospholipids bound in a ratio of one third each. In
addition, dissolved crystals of Ac 1,2-CTD exhibited the
same three bands on native homogeneous polyacrylamide
gels, thus indicating that a particular form of Ac 1,2-CTD
was not preferentially crystallizing. For these reasons the
phospholipids were refined as having half occupancy. This
resulted in a phospholipid with tail groups that have an
average thermal parameter of 15 Å2; this is a similar value
to that of several hydrophobic groups in contact with the
phospholipid tail. 
Despite soaking crystals in excess catechol and 4-methyl-
catechol, the resulting structures are a mixture of bound
and unbound states. Refinement after inclusion of sub-
strate left a 5σ difference peak that was continuous with
both the substrate molecule and the iron atom. This peak
overlaid the position of Wat501 seen in the native struc-
ture. Refinement of a model with substrate at two thirds
430 Structure 2000, Vol 8 No 4
st8401.qxd  03/29/2000  12:45  Page 430
occupancy, and Wat501 at one third occupancy resulted in
thermal parameters for the exogenous ligands that were
comparable with the endogenous ligands to the iron. In
addition, no residual difference density was noted in the
active site. Another source of heterogeneity could arise
from the incomplete incorporation of iron in the cloned
enzyme. In the case of Pp 3,4-PCD and Ac 3,4-PCD puri-
fied from the Escherichia coli clone, the active sites had
only 2–3 irons per dodecamer (MWV, unpublished obser-
vations). This appears to not be the case in the cloned
Ac 1,2-CTD in which typical iron occupancy is around
1.5–2.0 irons per dimer.
Structural overview
Ac 1,2-CTD is an elongated molecule (50 × 50 × 110 Å)
composed of helices and β sheets (see Figure 1). The
overall shape of the Ac 1,2-CTD dimer resembles a
boomerang that can be divided into three domains: the
two catalytic domains at each end of the boomerang, and
the linker domain at its center. The catalytic domains of
each monomer are at each end of the boomerang, whereas
the center is composed of several helices that constitute
the linker domain. Both active sites are accessible to the
substrate from the concave side of the dimer. The two
Fe3+ are separated by more than 40 Å and are believed to
be structurally and catalytically independent, as no
allostery has been reported [32]. The bound phospho-
lipids are located at the interface between the two dimers
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Table 1
Summary of data collection and refinement statistics.
Native 1 mM 30 mM 30 mM 
HgCl2 CAT 4-MC
Data collection
Cell axis (Å) 52.6, 87.6, 52.7, 87.6, 52.8, 87.5, 52.8, 88.0, 
84.2 84.0 84.4 84.4
β angle (°) 96.3 96.5 96.3 96.3
Resolution (Å) 2.0 2.3 1.9 1.7
Unique reflections 53,372 33,625 61,083 87,127
Completeness (%) 89.4 (76.2) 90.7 (45.9) 96.4 (85.0) 93.0 (60.0)
Redundancy 3.3 2.5 2.6 2.5
I/σI 21.4 (1.6) 31.0 (5.0) 15.7 (1.1) 17.5 (1.1)
Rmerge (%) 4.2 (20.3) 3.8 (11.8) 4.2 (27.9) 4.0 (29.4)
Phasing power* – 1.36/1.22 – –
20–2.5 Å (acentric/centric)
Refinement
Resolution range (Å) 20–2.0 20–2.3 20–1.9 20–1.8
Unique reflections 43,086 29,797 54,078 65,553
R factor (%) 19.6 18.2 18.7 18.5
Rfree (%)† 24.3 22.4 22.7 21.8
Water molecules 181 124 243 267
Rms bond lengths (Å) 0.007 0.007 0.014 0.011
Rms bond angles (°) 1.5 1.5 1.7 1.7
Statistics in parentheses are for highest resolution shell. *Phasing
power = the root mean square (FH/E), where FH is the calculated
structure-factor amplitude from the heavy atoms and E is the lack of
closure error. †Rfree = R factor calculated over subset of data.
Figure 1
Overview of the structure of Ac 1,2-CTD. (a) Location of molecular
domains, and active site. (b) Rotation of figure (a) by 90° around the
horizontal axis. Subunit A is in green and subunit B in red. Iron atoms
are shown as yellow spheres. (Parts a and b were generated using the
program MOLSCRIPT [66].) (c) Simple rendering of the secondary
structure of Ac 1,2-CTD. α Helices are in cyan and are labeled 1 to 7.
β strands are in yellow and are labeled A to N. Secondary structural
elements were assigned using the algorithm of Kabash and Sanders
[67] within the program PROCHECK [68].
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and bind in a tunnel that passes from one face of the
boomerang to the other.
Catalytic domain
The core of the catalytic domain contains two mixed topol-
ogy β sheets that stack against each other to form a β sand-
wich (see Figure 2). The active site is located between the
β sandwich of each monomer and the linker domain and is
enclosed by several long random coils. The iron is ligated
by four protein residues and a solvent in trigonal bipyrami-
dal geometry. Tyr200 and His226 are the axial ligands,
whereas Tyr164, His224, and a solvent molecule (Wat501)
make up the equatorial plane. The geometry is distorted
towards octahedral, with Tyr164 and His224 being nearly
90° apart. X-ray absorption spectroscopy (XAS) data on
hydroxyquinol 1,2-dioxygenase and chlorocatechol dioxy-
genase indicates that the enzyme is pentacoordinate with
two spheres of atoms; either two at 1.9 Å and three at 2.1 Å,
or three at 1.9 Å and two at 2.1 Å [33]. In the crystal struc-
ture, the iron is pentacoordinate, however, the resolution is
insufficient to determine the distances as accurately as
with XAS. Tyr164 has the shortest bond (~1.85 Å); His226
(~2.0 Å), His224 (~2.15 Å) and Tyr200 (~2.20 Å) exhibits a
mid-range bond; Wat501 (~2.35 Å) has the longest bond.
Electron paramagnetic resonance (EPR) data on 3,4-PCD
show that one of the ligands to the iron is a water molecule
[18] and the extended X-ray absorption fine structure
(EXAFS) suggests that the water molecule is a hydroxide
[14]. In Ac 1,2-CTD, the water to iron distance is longer
than that seen in Pp 3,4-PCD (2.35 versus 1.9 Å), but this
might be due to a difference in the pH at which the data
was collected (pH 8.5 versus pH 7.5). In the structure of Ac
3,4-PCD at low pH, the equatorial solvent molecule also
binds at a longer distance, although there is a sulfate mol-
ecule binding the iron in the equatorial plane (MWV,
unpublished observations).
Comparison of Ac1,2-CTD with Pp 3,4-PCD
A global sequence alignment of Ac 1,2-CTD and the
β subunit of Pp 3,4-PCD yields a sequence identity of
21.5%. Restricting the alignment to the structurally
similar regions of Ac 1,2-CTD (residues 131–293) and Pp
3,4-PCD (residues 375–528) raises the identity to 30.9%.
A structural superposition of the two proteins in this
region yields a root mean square (rms) of 1.4 Å for 116 Cα
atoms. There are considerable differences among the
residues on the outer surface of the proteins, which are
consistent with the differences in oligomeric structures of
the two enzymes. 1,2-CTDs are homodimers whereas
3,4-PCDs are heterodimers that pack together to form
higher order oligomers. Depending on the source from
which they are purified,  3,4-PCDs have been found to
contain two [34], four [16], six [35], or 12 protomers [9,36]
in the holoenzyme. Pp 3,4-PCD is a dodecamer in which
the β subunits of each protomer assemble into a core
sphere, with the α subunits projecting outwards. Figure 3
shows a superposition of Pp 3,4-PCD and Ac 1,2-CTD.
Several hydrophobic groups that project from one side of
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Figure 2
Stereoview of a monomer of Ac 1,2-CTD. The
figure is positioned such that the helices
comprising one half of the linker domain are
shown at the top. Every twentieth residue is
labeled. The iron atom is shown as a
black sphere. 
st8401.qxd  03/29/2000  12:45  Page 432
the β subunit and are involved in the oligomeric interface
in Pp 3,4-PCD are hydrophilic residues in Ac 1,2-CTD
because the surface is completely exposed to solvent. In
Pp 3,4-PCD two long- random coils at the N terminus
form a basket perpendicular to the β sandwich. The 
α subunit sits in this basket and inserts its N terminus
between the coils and the β sandwich. In Ac 1,2-CTD
these interactions are replaced by a short coil at the C ter-
minus, helices 4 and 5, and a coil connecting the linker
domain to the β-sandwich. This coil also makes up one
wall of the active site, contributing residues Pro108 and
Leu109. In Pp 3,4-PCD the N terminus of the α subunit
forms a portion of the active site, contributing residues
Thr12, Pro15 and Tyr16. It is interesting to note that a
proline in the active site is structurally conserved
between the enzymes, despite being from different parts
of the sequence and from disparate portions of the struc-
ture. In Pp 3,4-PCD, Pro15 interacts with one side of the
aromatic ring of the substrate. 
The active site of Pp 3,4-PCD is considerably more
hydrophilic than that of Ac 1,2-CTD. This is reasonable as
the substrate has a carboxylate moiety. In addition, despite
having a large overall negative charge, Pp 3,4-PCD has
several basic groups surrounding the opening to the active
site. It has been postulated that these basic groups provide
an electrostatic potential to guide the substrate to the
active site [7]. Pp 3,4-PCD and Ac 1,2-CTD have similar
large negative charges. In Ac 1,2-CTD, however, there are
no basic residues at the entrance to the active site. This
adds credibility to the idea that these charges are needed
in 3,4-PCDs for it to bind the negatively charged substrate. 
Linker domain
The linker domain is comprised of 12 α helices: five from
the N terminus of each monomer and one extending from
each catalytic domain. Helices 1–3 reach across from one
subunit to interact with helices 4 and 5 of the correspond-
ing monomer. Helices 4 and 5 lie against the catalytic
domain, with helix 4 donating residues Leu73 and Pro76
to the active-site cavity. Viewing down the center of the
linker domain along the molecular twofold shows the pres-
ence of a large 8 × 35 Å hydrophobic tunnel. Two phos-
pholipids, one at each end, are bound in this tunnel. Each
phospholipid is bound with the head group pointed out-
wards into the solvent (with no visible electron density)
and the tail groups pointing inwards towards each other.
Figure 4 shows the quality of the electron density for the
phospholipid and the hydrophobic groups that line the
tunnel. The hydrophobic portion of the amphipathic
helices 2–4 and 6 point inwards towards the phospholipid.
Residues Val30, Ile33, Ile45, Tyr55, Tyr61, Leu62,
Leu65, Leu74, Leu78, Phe80 and Leu211 form the
hydrophobic surface of the tunnel. Residues from both
subunits are in contact with each phospholipid. A
sequence alignment of several 1,2-CTDs is given in the
Supplementary material. Residues that line the tunnel are
conserved across the 1,2-CTD family and are exclusively
hydrophobic, thus, suggesting that this is a common
feature of these enzymes. The aliphatic tail groups of each
phospholipid splay apart from each other as the tunnel
widens at its center. The structures of several proteins
that exclusively use α helices to sequester hydrophobic
molecules from solvent are known. These include serum
albumin [37] and nonspecific lipid-transfer proteins [38].
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Figure 3
Structural alignment of an Ac 1,2-CTD
monomer and a protomer of Pp 3,4-PCD
[7,8]. The Cα trace of Ac 1,2-CTD is shown
in red, with the helix-linker domain at the
bottom and the catalytic domain at the top.
The four ligands to the iron and catechol are
shown in black, whereas the iron atom is
displayed as a yellow sphere. Each
Pp 3,4-PCD protomer is composed of an
α subunit (thin black line) and a β subunit
(green) . The two proteins were aligned using
the catalytic domain of Ac 1,2-CTD and the
β subunit of Pp 3,4-PCD. The figure was
generated using the program SETOR [69].
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There does not appear to be any evolutionary relationship
between these proteins and Ac 1,2-CTD.
It is interesting to speculate on the role of the hydropho-
bic tunnel; one possibility could be that it increases the
local concentration of substrate. This is unlikely,
however, because catechol is soluble to concentrations
above those which would be seen physiologically, and
there is no direct pathway from the hydrophobic tunnel
to the active site. 
A second hypothesis is that the lipid acts as an effector
molecule. It could communicate through to the active
site by two methods. Firstly, helix 4 has residues that are
located both in the tunnel and in the active site. Leu74
and Leu78 could interact with the lipid whilst Leu73 is
in contact with the substrate. Secondly, the loop that
extends from strands G and J of the β sandwich passes
over the active site and includes helix 6, which provides
Leu210, Leu211 and Leu214 to the hydrophobic tunnel.
In both of these cases, the binding of phospholipid might
lead to a conformational change at the active site. The
reason for using an effector is open to speculation. It is
possible that  the organism delays the activation of catal-
ysis until the protein is located in a certain part of the
cell. This could be used to keep the intercellular levels
of the product, which is known to be toxic to the cell, at
low levels. Perhaps the next enzyme in the β-ketoadi-
pate pathway, cis-cis-muconate lactonizing enzyme, inter-
acts with the hydrophobic tunnel and allows the proteins
to pass the product from one enzyme to the next. 
A final hypothesis for the role of the hydrophobic tunnel
is that it regulates of the fluidity of the phospholipid
bilayer.  Phenolic hydrocarbons are known to have
antimicrobial properties because of their ability to affect
the integrity and function of the cell membrane [39,40].
Several species of soil bacteria have evolved mechanisms
to overcome this toxicity. One mechanism is an energy-
dependent active efflux pump to lower the cellular con-
centrations of certain hydrocarbons [41,42]. A second
mechanism is an alteration of the phospholipid bilayer to
increase membrane rigidity and exclude external
hydrophobic compounds. This is achieved through an
increase in trans phospholipids [43–45], modification of
phospholipid polar head groups [46,47] and an increase in
phospholipid turnover [48]. As members of the 1,2-CTD
family are involved in the degradation of several pheno-
lic hydrocarbons that are known to affect membrane
composition, the binding of phospholipids to these pro-
teins is an extremely interesting observation. 1,2-CTDs
might be able to directly influence membrane composi-
tion by binding phospholipids of a specific character. 
1,2-CTD might extract phospholipids  directly from the
membrane or might bind the phospholipids as they are
synthesized by the cellular machinery. It is interesting to
note that all three ester linkages of the phospholipid are
presented at the surface of the molecule where the head
group could be subject to modification or exchange. This
suggests that 1,2-CTDs might act as an intermediary
between the membrane and a second enzyme. It is
unlikely that 1,2-CTDs catalyze an alteration of phos-
pholipids themselves. Tyr55 and Ser75 are the only polar
amino acids in contact with the fatty-acid groups of the
phospholipid and are not conserved across the enzyme
family. Understanding the role of lipid in Ac 1,2-CTD
requires further study. 
The program CE [49] was used to search the Protein Data
Bank (PDB) for structural homologues to the linker
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Figure 4
Stereo drawing of residues around one of two
bound phospholipids. Residues from subunit
A are shown in red, while those from subunit
B are shown in green. Also displayed is +4α
Fo–Fc electron density from an omit map
calculated without the phospholipid in the
model. The figure was prepared using the
molecular graphics program O [64].
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domain. Searches with helices 1–5 yielded matches with
GroEL [50] (65/93 Cα atoms, rms = 3.8 Å, Z score = 4.1,
sequence identity 3.1%) and cytochrome bc1 complex
[51] (71/93 residues, RMS = 4.0 Å, Z score = 4.1, sequence
identity 8.5%). The matching residues are restricted to
helices 1–3, indicating that helices 4 and 5 are in a novel
conformation. It is possible that the model was traced
incorrectly, as the loop between helix 3 and 4 passes
within 3.5 Å of the corresponding loop in the other
subunit. As a test, we created a chimeric search model
that included helices 1–3 linked to helices 4′ and 5′ of the
neighboring subunit. The best structural homologue was
the helical domain of phosphoenolpyruvate (PEP): sugar
phosphotransferase complex system (PTS) enzyme I (EI)
[52]. Superposition of the search model on the helical
domain of EI results in an rms deviation of 3.5 Å for 85
Cα atoms (sequence identity 10.6%). Careful examina-
tion of the initial SIR maps in this area confirmed the
initial trace. Although the exchange of secondary struc-
tural elements is known to occur in dimerization [53], to
our knowledge there are no examples of any other protein
that uses this helical fold. 
Substrate complexes
The structures of Ac 1,2-CTD complexes confirm the
pentacoordination of the Fe3+ observed by Briganti et al.
[33]. The binding of catechol and 4-methylcatechol to Ac
1,2-CTD leads to the dissociation of Wat501 and Tyr200.
Figure 5 shows two perpendicular views of the active-site
residues in the final models, with the corresponding
2Fo–Fc density overlaid. The ligand-to-metal distances of
the substrate are comparable to those seen for the binding
of 3,4-dihydroxybenzoate to Pp 3,4-PCD [22]. Figure 6a
shows a general view of the iron ligands of Ac 1,2-CTD
before and after substrate binding. One hydroxyl group of
substrate binds in an axial position trans to His226 and the
other binds in an equatorial position trans to Tyr164. The
ligand position trans to His224 is unoccupied. The active-
site geometry can be described as octahedral with one
equatorial position open. The area around the open equa-
torial position is postulated to be the oxygen-binding
pocket. A comparison of Pp 3,4-PCD to Ac 1,2-CTD indi-
cates that residues lining this pocket are conserved, sug-
gesting similar interactions of these residues with
oxygen. Figure 6b shows an overlay of Ac 1,2-CTD and
Research Article  Structure of catechol 1,2-dioxygenase Vetting and Ohlendorf    435
Figure 5
2Fo–Fc electron density for the native and the two complexes around the
active site. The electron density is contoured at 1σ. (a) Ac 1,2-CTD with
no substrate bound. (b) Ac 1,2-CTD soaked with 30 mM catechol. (c) Ac
1,2-CTD soaked with 30 mM 4-methylcatechol. (d,e,f) Same conditions
as (a,b,c) only the model is rotated 90° around the horizontal axis. The
figure was prepared with the molecular graphics program O [64].
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Pp 3,4-PCD active sites after binding their physiological
substrates. Tyr200 does not hydrogen bond to any atoms
after it dissociates from the iron. The hydroxyl group of
Tyr200 is directed towards the solvent and is probably sol-
vated by disordered water. This is in contrast to the tyro-
sine ligand of Pp 3,4-PCD, which hydrogen bonds to Tyr16
of the α subunit. Leu109 replaces Tyr16 in Ac 1,2-CTD.
Mutating Tyr447 to a histidine in Pp 3,4-PCD leads to an
enzyme with a kcat 600-fold lower than that of the wild-
type enzyme [54]. Single-turnover kinetics of this mutant
suggest that Tyr447 is important in the substrate binding
and product release step, and has very little effect on the
oxygenation step. Stopped-flow kinetic studies indicate
that 1,2-CTDs and 3,4-PCDs have similar enzyme inter-
mediates and proceed by similar mechanisms [55]. The
affinity of the tyrosine ligand for the iron could be modu-
lated by the type of interactions the tyrosine forms with
the protein after it dissociates from the iron. This might
be correlated with the affinity of the substrate or the
product for the same axial site and therefore, could be
used to enhance catalysis of a particular substrate. 
The main interactions of the enzyme with the substrate
involve residues Leu73, Pro76, Ile105, Pro108, Leu109,
Arg221, Phe253 and Ala254. The active site of Ac 1,2-CTD
is approximately equal in size to Pp 3,4-PCD but is less
hydrophilic, because groups that hydrogen bond to and
compensate for the negative charge on 3,4-dihydroxyben-
zoate are not conserved. Tyr324, which hydrogen bonds to
the carboxylate of substrate in Pp 3,4-PCD, is replaced by
Pro76 and Leu78 of helix 4. Pro108 is structurally conserved
between 3,4-PCDs and 1,2-CTDs, despite arising from
disparate portions of the sequence. Residue Trp449 of Pp
3,4-PCD has been implicated in the positioning of sub-
strate. This residue is replaced by Phe253 in the 1,2-CTDs
and might serve a similar role.  An arginine residue that is
buried upon binding to the substrate is conserved across all
1,2-CTDs and 3,4-PCDs. In Ac 1,2-CTD, Arg122 is within
hydrogen-bonding distance of one of the hydroxyl groups of
the substrate. This arginine might function by positioning
the hydroxyl to bind correctly to the iron, providing signifi-
cant van der Waals interactions with the ring to prevent its
rotation into two equatorial positions and/or providing an
electrostatic countercharge to the build up of electron
density on a carbon atom of the ring. In Ac 3,4-PCD, a
mutation of this arginine to a serine caused a null pheno-
type, thus indicating the importance of this residue [10].
4-Methylcatechol binds in a similar fashion to Ac
1,2-CTD, as catechol although the aromatic ring has
rotated slightly and tilted to avoid a steric conflict with
Pro76. Aromatic compounds that have larger substituents
than a methylene group (e.g., protocatechuate, 4-nitrocate-
chol and homoprotocatechuate) are not able to bind in a
catalytically competent fashion because they would inter-
act unfavorably with Pro76, Leu73 and Ile105. This is
borne out in kinetic data that show that although the aro-
matic compounds bind, they are not turned over by the
enzyme [55]. Perhaps they only ligate the iron through one
of the hydroxyls or become trapped in an initial binding
mode unable to rotate fully into the active-site cavity. 
Catecholates with the substituents on the C3 have two
possible binding orientations, when chelating the iron. In
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Figure 6
A comparison of the binding of substrate by
Ac 1,2-CTD and Pp 3,4-PCD. (a) Orientation
and numbering of active site ligands in
unbound and bound states (corresponding
residue numbering of Pp 3,4-PCD in
parenthesis). (b) Superposition of active site
residues of Ac 1,2-CTD in red and Pp 3,4-
PCD α subunit in gray, β subunit in green with
bound catechol in yellow and protocatechuate
in cyan respectively. Part b was generated
using the program SETOR [69].
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one orientation the substituent would settle into a pocket
created by residues Ile105, Pro108, His226, Gln240 and
Arg221. All of these residues are conserved in the
1,2-CTD family and therefore differences in substrate
specificity would be governed by larger global effects in
this region. The alternative orientation would yield steric
conflicts with Tyr200. A significant rearrangement in the
active site might allow a substituent on C3 to interact with
the pi electrons of Tyr200.
The substrate specificity of the 1,2-CTD family of
enzymes might be specified to a significant degree by
residues of helix 4. In Ac 1,2-CTD and in 1,2-CTD from
P. arvilla (C Earhart, personal communication), this helix
is conserved; Pro76 and Leu73 interact with C3 and C4 of
the substrate. In the chlorocatechol dioxygenases (CCDs)
and the 1,2-CTDs from Rhodococci sp. a portion of the
helix appears to be missing. These enzymes are capable of
catalyzing 4-methylcatechol at rates approaching that of
the physiological substrate catechol [24,56]. The hydrox-
yquinol dioxygenases (1,2-HQDs) retain residues at this
position but there is no sequence homology to Ac
1,2-CTD. It is possible that a hydrophilic group such as
Arg73, Gln74, Glu75 or Ser80 interacts with the hydroxyl
on C4 of hydroxyquinol, forming a hydrogen bond crucial
for positioning of the substrate.
A significant difference between Ac 1,2-CTD and the
CCDs is that residues 253 and 254 are almost always cys-
teines in CCDs but are almost always hydrophobic groups
in 1,2-CTDs and 1,2-HQDs. Residues 253 and 254 are in
direct contact with the substrate in Ac 1,2-CTD. The cys-
teines might be important in the binding and catalysis of
catecholates that contains halogens.
Mode of inhibition by HgCl2
Mercury was the first (and only) heavy atom derivative
attempted in the SIR structural solution of Ac 1,2-CTD.
Reasonable success was suggested from three pieces of
biochemical data. Firstly, Ac 1,2-CTD has a single cys-
teine, and therefore we expected one binding site per
monomer and an interpretable Patterson map. Secondly,
the single cysteine (Cys202) through sequence homology
with Pp 3,4-PCD was believed to be located within the
active site. This gave us confidence that the site was
solvent exposed, but was going to be on a relatively rigid
part of the structure. Thirdly, incubating Ac 1,2-CTD
with 1 mM HgCl2 inactivates the enzyme. We refined the
enzyme mercury derivative in an attempt to determine
the mode of inhibition of HgCl2. Three mercury atoms
bound per monomer. One mercury (Hg3) bound to Met86
and His82 on the surface-exposed side of helix 5. This
mercury should have no effect on turnover as it is 15Å
from the active site and located on the opposite face of the
molecule in relation to the active-site entrance. The other
mercury atoms (Hg1 and Hg2) bound to Cys202, which is
in two conformations. It was assumed that the binding of
mercury at this site blocks access of the substrate to the
active site. This does not appear to be the case as Hg2 is
over 9.5Å from the bound catechol, where it interacts with
the solvent-exposed surface of helix 6. Hg1 is closer to the
important residues of the active-site, binding to the inside
of the active site wall that is formed by strands H and I.
Hg1 would be ~5.5 Å from the bound catechol and 3.5 Å
from Tyr200, once it has dissociated from the iron. Hg1
and Hg2 do not significantly restrict the active site
entrance from bulk solvent. Examination of the structures
suggests that the inhibition is due to an effect on the
ability of Tyr200 to dissociate. This effect might be direct
as a simple rotation of its sidechain brings the hydroxyl
group of Tyr200 to within 3.5 Å of Hg1. The effect,
however, might be indirect, from increasing the rigidity of
the polypeptide backbone of the segment containing
Tyr200. Hg1 and Hg2 make several positive interactions
between strands H, I and helix 6 and essentially lock this
region of protein structure in place. It might be a common
feature among intradiol dioxygenases that a region of flex-
ibility downstream from the dissociating ligand is required
for catalysis. The intrinsic flexibility of this region could
be exploited by an organism as a method to affect the cat-
alytic rate of the enzyme. Indeed this might be true for Ac
1,2-CTD as helix 6 makes important contacts with the
potential effector molecule in the hydrophobic tunnel. 
Biological implications
Aromatics are one of the most prevalent classes of com-
pounds in the global carbon cycle. The industrialization
of our society has led to a dramatic increase in the
number and volume of novel aromatics released into the
environment. These xenobiotic compounds often have
toxic biological properties and are recalcitrant to
biodegradation. The accumulation of these compounds
has focused attention on the biochemical pathway of
organisms capable of transforming complicated aromat-
ics into simpler organic molecules. The three-dimen-
sional structure of critical enzymes in these
pathways,therefore, is, of great interest to the bioremedi-
ation field. 
The catabolism of aromatic compounds involves their
hydroxylation to form catecholates that then undergo
ring cleavage by a dioxygenase. The dioxygenase family
of enzymes is divided into two classes, intradiol and
extradiol, depending on the point of ring cleavage. Intra-
diol dioxygenases utilize a non-heme ferric ion to bind
and cleave the aromatic ring, with the concomitant
incorporation of both atoms of molecular oxygen. Intra-
diol dioxygenases can be subdivided into two subclasses
(catechol 1,2-dioxygenases; 1,2-CTDs and protocate-
chuate 3,4-dioxygenase; 3,4-PCDs) on the basis of their
substrate specificity and oligomeric state. 3,4-PCDs
consist of two homologous but non-identical subunits in
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large oligomeric complexes (αβFe3+)2–12 and are specific
for 3,4 dihydroxybenzoate. 1,2-CTDs are homodimers
and can catalyze the cleavage of a wide range of sub-
strates from catechol to multiply halogenated aromat-
ics. The wide substrate specificity of this subclass
makes 1,2-CTDs an attractive target in the design of
enzyme systems for bioremediation. 
In this study, we present the crystal structure of catechol
1,2-dioxygenase from Acinetobacter sp., ADP1 (Ac 1,2-
CTD) together with its complexes with catechol and
4-methylcatechol. Ac 1,2-CTD exists as a boomerang-
shaped (αFe3+)2 dimer. The catalytic domain consists of
two mixed topology β sheets folded into a β sandwich
similar to that seen in 3,4-PCDs. In addition to residues
that ligate the iron, 3,4-PCDs and 1,2-CTDs share
several first and second sphere residues that are critical
to binding and activating the substrate. There are,
however, substantial changes in the shape and nature of
the outer binding pocket because of the difference in sub-
strates recognized by 3,4-PCDs and 1,2-CTDs. An
examination of residues critical to binding together with
sequence alignments indicates several residues that might
be key to the diverse substrate specificity of 1,2-CTDs.
The structures demonstrate that endogenous ligand
displacement upon chelating substrate is probably a
common theme in all known intradiol dioxygenases.
Five N-terminal helices are used from each subunit to
form a novel ‘helical zipper’ linking the two catalytic
domains together. Two phospholipids were found to be
bound in an 8 × 35Å tunnel located down the center of
the linker. The structure suggests that this part of the
molecule could act as an effector region modulating the
activity of the enzyme or it might be involved in altering
the composition of the phospholipid bilayer. Sequence
analysis indicates that the helical zipper is a conserved
motif among all members of the 1,2-CTD family. A com-
parison of the quaternary structure of 3,4-PCDs and 1,2-
CTDs indicate that the two families of intradiol
dioxygenases are more distantly related than first hypoth-
esized.
Materials and methods
Purification and crystallization
Ac 1,2-CTD was overexpressed in an E. coli strain (B834DE3,
Novagen) harboring the plasmid pIB1343 [57]. Frozen cells were
resuspended 2:1 (w/v) in buffer A (50 mM Tris-HCl pH 8.5), disrupted
with a sonicator and then centrifuged. Proteins were precipitated with
an ammonium sulfate cut of 35–55%, and then centrifuged. After
resuspending the pellet in a minimal volume of buffer A, the resultant
extract was applied to a 5 × 160 cm Sephacryl-300 (Pharmacia) gel fil-
tration column. Fractions with high activity were pooled and then
applied to a 2.5 × 30 cm DEAE (POROS) anion exchange column. Ac
1,2-CTD eluted around 0.2 M NaCl in a 0–0.4 M NaCl gradient in
buffer A. Fractions with high activity were pooled, made 1.0 M in
ammonium sulfate, and then applied to a 2.5 × 30 cm Phenyl
Sepharose (Pharmacia) column. Ac 1,2-CTD eluted as a pure peak at
< 0.1 M ammonium sulfate in a 1.0–0.0 M ammonium sulfate gradient
in buffer A. Ac 1,2-CTD was then concentrated by centrifugal ultrafiltra-
tion to 60 mg/ml in 10 mM Tris-HCl pH 8.5. A typical enzyme prep
yielded enzyme with a specific activity of 12–14 units/mg using the
assay of Fujiwara et al. [58]. The protein was crystallized at 4°C, using
the hanging drop vapor diffusion method. The drops consisted of 5 µl
of protein at 60 mg/ml, and 5 µl of reservoir solution equilibrated
against 1 ml of reservoir solution. The latter contained 15% polyethyl-
ene glycol (PEG) 5000 and 200 mM magnesium acetate in 100 mM
Tris-HCl pH 7.5. Infrequently nucleation would occur and a single
0.4 × 0.4 × 0.8 mm rectangular crystal would form. Micro and macro
seeding circumvented the low rate of nucleation and allowed the gen-
eration of several large crystals.
Data collection and processing
The crystals belong to space group P21, with unit cell dimensions of
a = 52.6 Å, b = 87.6 Å, c = 84.2 Å and α = 96.3°. The asymmetric unit
contains one Ac 1,2-CTD molecule (dimer) corresponding to a VM
value of 2.8 Å3/Da, which is within the range reported by Matthews
[59]. Data were measured at 24°C using a Siemens High Star detector
system with graphite monochromatized Cu-Kα radiation from a Rigaku
RU200 rotating anode generator operating at 45 kV and 200 mA. X-ray
data were scaled and merged using the program XENGEN [60]. Data
collection and processing statistics are summarized in Table 1.
Structure determination and refinement
One heavy-atom derivative, mercury chloride (HgCl2) was used for the
phase determination. The same crystal that was used for the native
data set was removed from the capillary and soaked for 3 h in the origi-
nal reservoir solution supplemented with 1 mM mercury chloride. A
second data set was collected on this crystal after which heavy-atom
sites were located by difference Patterson and Fourier difference
maps. Each monomer of Ac 1,2-CTD contains three mercury sites (see
text for details). Heavy-atom parameters were refined using the
program MLPHARE [61]. The program DM [62] in the CCP4 [63] was
used to improve the phases through solvent flattening and histogram
matching. Initial electron density maps were of sufficient quality to
exhibit the iron atoms as the highest peaks, and allowed tracing
residues 222–228 in each monomer. This initial trace was used to
obtain the noncrystallographic twofold operator, which the three
mercury sites per monomer were found to follow. Inclusion of noncrys-
tallographic symmetry averaging in the refinement of phases in DM
greatly improved the resultant electron-density maps.
Model building was performed using the interactive computer graphics
program O [64], and all refinement procedures used the program CNS
[65]. The initial model had over 90% of the polypeptide chain placed in
the original 2.5 Å SIR-DM phased maps. The resultant model was
refined using molecular dynamics from a starting temperature of 6000K,
using all data to 2.0 Å. Alternate steps of manual rebuilding, positional
refinement, and thermal parameter refinement were used to improve the
structure. No geometric constraints were placed on the ligands to the
iron during refinement. All van der Waals interactions to the iron were
removed so that refinement of the positions of the ligands were guided
by the electron density only. Noncrystallographic symmetry restraints
were used in the initial refinement steps until all the residues were
modeled, whereupon the restraints were released. Water molecules
were included in the structure only if their geometry met hydrogen
bonding requirements and had peaks above 4σ in the Fo–Fc difference
maps that were consistent with peaks in 2Fo–Fc maps. 
Catechol and 4-methylcatechol complexes
Aerobically grown crystals were transferred to an anaerobic hood (Coy
Systems) and washed several times in anaerobic mother liquor before
catechol or 4-methylcatechol to a final concentration of 30 mM. The
crystals were soaked for a period of 3 h, however, an immediate color
change of burgundy to blue-gray indicated that the substrate pene-
trated the active sites fairly quickly. The capillary was sealed with
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mineral oil and then with epoxy to keep the sample anaerobic. The
refined coordinates of Ac 1,2-CTD were purged of all heteroatoms and
subjected to rigid body refinement and molecular dynamics to remove
phase bias. Fo–Fc difference maps indicated clear density for the
bound substrate, and for Tyr200 in an alternate conformation. Model
building proceeded as was the case in the native state with no geomet-
ric constraints or van der Waals interactions on ligands to the iron.
Accession numbers
The atomic coordinates for Ac 1,2-CTD, and Ac 1,2-CTD in complex
with Hg, CAT and 4-MC have been deposited in the Protein Data Bank
with accession numbers 1DLM, 1DLQ, 1DLT and 1DMH, respectively.
Supplementary material
Supplementary material including a sequence alignment of 1,2-CTD dioxy-
genases and a figure to show the interactions of Ac 1,2-CTD with 
two heavy atoms is available at http://current-biology.com/supmat/sup-
matin.htm.
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